Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging
ConditionAging
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-60
SponsorCosmetique Active International
About this trial
This experimental, randomized study aims at evaluating the preventative effect of a Sun Protection Factor (SPF) 50+ sunscreen (Anthelios UVMUNE 400 Fluid SPF 50+) with high Ultraviolet A (UVA) protection on clinical signs of skin aging.
Eligibility criteria
Qualifiers
Subjects with signs of photo aging (Global score of at least 14)
All skin types
Disqualifiers
Any history of significant dermatological/ophthalmological diseases or conditions or medical conditions known to alter skin appearance or physiologic response (e.g. diabetes,) which could, in the opinion of the Investigator, preclude topical application of the investigational products and/or interfere with the evaluation of the test site
Pregnant or breastfeeding women
Subject with known allergy to cosmetic products or to any ingredient of the sunscreen product
Trial design
Treatments tested in this trial
- Tested product group
- Control group
Treatment groups
260 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov